[1] |
Tanner MM, Tirkkonen M, Kallioniemi A, et al. Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes[J]. Cancer Res,1994,54(16):4257-4260.
|
[2] |
Nikonova AS, Astsaturov I, Serebriiskii IG, et al. Aurora A kinase (AURKA) in normal and pathological cell division[J].Cell Mol Life Sci,2013,70(4):661-687.
|
[3] |
Wang Y, Wang Z, Qi Z, et al. The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression,cytokinesis, and tetraploidy[J]. Mol Cancer,2014,13:94.
|
[4] |
Pérez de Castro I, Aguirre-Portolés C, Fernández-Miranda G,et al. Requirements for Aurora-A in tissue regeneration and tumor development in adult mammals[J]. Cancer Res,2013,73(22):6804-6815.
|
[5] |
Sen S, Zhou H, White RA. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines[J]. Oncogene,1997,14(18):2195-2200.
|
[6] |
Miyoshi Y,Iwao K,Egawa C,et al. Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers[J]. Int J Cancer,2001,92(3):370-373.
|
[7] |
Rouquier S, Pillaire MJ, Cazaux C, et al. Expression of the microtubule-associated protein MAP9/ASAP and its partners AURKA and PLK1 in colorectal and breast cancers[J]. Dis Markers,2014,2014:798 170.
|
[8] |
Wang X, Zhou YX, Qiao W, et al. Overexpression of Aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation[J]. Oncogene,2006,25(54):7148-7158.
|
[9] |
Meraldi P, Honda R, Nigg EA. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells[J]. EMBO J,2002,21(4):483-492.
|
[10] |
Zhang H, Chen X, Jin Y, et al. Overexpression of Aurora-A promotes laryngeal cancer progression by enhancing invasive ability and chromosomal instability [ J ]. Eur Arch Otorhinolaryngol,2012,269(2):607-614.
|
[11] |
Roylance R, Endesfelder D, Jamal-Hanjani M, et al.Expression of regulators of mitotic fidelity are associated with intercellular heterogeneity and chromosomal instability in primary breast cancer[J]. Breast Cancer Res Treat,2014,148(1):221-229.
|
[12] |
Oda-Sato E,Tanaka N. Abnormal centrosome amplification and Aurora-A activation in p53-deficient cells[J]. J Nippon Med Sch,2007,74(6):384-385.
|
[13] |
Katayama H, Sasai K, Kawai H, et al. Phosphorylation by Aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53[J]. Nat Genet,2004,36(1):55-62.
|
[14] |
Zorba A, Buosi V, Kutter S, et al. Molecular mechanism of Aurora A kinase autophosphorylation and its allosteric activation by TPX2[J]. Elife,2014,3:e02667.
|
[15] |
Furukawa T, Kanai N, Shiwaku HO, et al. AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer[J]. Oncogene,2006,25(35):4831-4839.
|
[16] |
Sankaran S, Crone DE, Palazzo RE, et al. Aurora-A kinase regulates breast cancer associated gene 1 inhibition of centrosome-dependent microtubule nucleation[J]. Cancer Res,2007,67(23):11 186-11 194.
|
[17] |
Xu LZ, Long ZJ, Peng F, et al. Aurora kinase a suppresses metabolic stress-induced autophagic cell death by activating mTOR signaling in breast cancer cells[J]. Oncotarget,2014,5(17):7498-7511.
|
[18] |
Opyrchal M, Salisbury JL, Zhang S, et al. Aurora-A mitotic kinase induces endocrine resistance through down-regulation of ERα expression in initially ERα+ breast cancer cells[J]. PLoS One,2014,9(5):e96995.
|
[19] |
Zheng XQ, Guo JP, Yang H, et al. Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer[J]. Oncogene,2014,33(42):4985-4996.
|
[20] |
Sun H, Wang Y, Wang Z,et al. Aurora-A controls cancer cell radio- and chemoresistance via ATM/Chk2-mediated DNA repair networks[J]. Biochim Biophys Acta,2014,1843(5):934-944.
|
[21] |
Katayama H, Wang J, Treekitkarnmongkol W, et al. Aurora kinase-A inactivates DNA damage-induced apoptosis and spindle assembly checkpoint response functions of p73[J].Cancer Cell,2012,21(2):196-211.
|
[22] |
Long M, Yin G, Liu L, et al. Adenovirus-mediated Aurora A shRNA driven by stathmin promoter suppressed tumor growth and enhanced paclitaxel chemotherapy sensitivity in human breast carcinoma cells[J]. Cancer Gene Ther,2012,19(4):271-281.
|
[23] |
Li JP, Yang YX, Liu QL, et al. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells[J].Drug Des Devel Ther,2015,9:1627-1652.
|